A Common Platform for Antibiotic Dereplication and Adjuvant Discovery

Cell Chemical Biology

Volumn 24, Issue 1, 2017, Pages 98-109

  Cox, Georgina ^a   Sieron, Arthur ^a   King, Andrew M ^a   De Pascale, Gianfranco ^a   Pawlowski, Andrew C ^a   Koteva, Kalinka ^a   Wright, Gerard D ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

adjuvant; antibiotic; antibiotic resistance; dereplication; natural products; potentiation

Indexed keywords

ADJUVANT; AMINOCYCLITOL; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CHLORAMPHENICOL DERIVATIVE; ECHINOMYCIN; FOSFOMYCIN; LINCOSAMIDE; MACROLIDE; POLYMYXIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMYCIN DERIVATIVE; SIDEROMYCIN; STREPTOGRAMIN DERIVATIVE; STREPTOTHRICIN; TETRACYCLINE DERIVATIVE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; PHARMACEUTICAL VEHICLES AND ADDITIVES;

ACTINOBACTERIA; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; DRUG RESEARCH; GENE EXPRESSION; HETEROLOGOUS EXPRESSION; NONHUMAN; PRIORITY JOURNAL; BACTERIUM; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DEVELOPMENT; DRUG EFFECT; HIGH THROUGHPUT SCREENING;

ADJUVANTS, PHARMACEUTIC; ANTI-BACTERIAL AGENTS; BACTERIA; DRUG DISCOVERY; DRUG RESISTANCE, BACTERIAL; HIGH-THROUGHPUT SCREENING ASSAYS; MOLECULAR STRUCTURE;

EID: 85010002052     PISSN: 24519456     EISSN: 24519448     Source Type: Journal    
DOI: 10.1016/j.chembiol.2016.11.011     Document Type: Article

References (50)

1. Baba, T., Ara, T., Hasegawa, M., Takai, Y., Okumura, Y., Baba, M., Datsenko, K.A., Tomita, M., Wanner, B.L., Mori, H., Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. Mol. Syst. Biol., 2, 2006, 2006.0008.
2. Baltz, R.H., Antibiotic discovery from actinomycetes: will a renaissance follow the decline and fall?. SIM News 55 (2005), 186–196.
3. Baym, M., Stone, L.K., Kishony, R., Multidrug evolutionary strategies to reverse antibiotic resistance. Science, 351, 2016, aad3292.
4. Bolivar, F., Rodriguez, R.L., Greene, P.J., Betlach, M.C., Heyneker, H.L., Boyer, H.W., Crosa, J.H., Falkow, S., Construction and characterization of new cloning vehicles. II. A multipurpose cloning system. Gene 2 (1977), 95–113.
5. Boucher, H.W., Talbot, G.H., Bradley, J.S., Edwards, J.E., Gilbert, D., Rice, L.B., Scheld, M., Spellberg, B., Bartlett, J., Bad bugs, no drugs: no ESKAPE!. Am. Clin. Infect. Dis. 48 (2009), 1–12.
6. Braun, V., Pramanik, A., Gwinner, T., Koberle, M., Bohn, E., Sideromycins: tools and antibiotics. Biometals 22 (2009), 3–13.
7. Brown, E.D., Wright, G.D., Antibacterial drug discovery in the resistance era. Nature 529 (2016), 336–343.
8. Bush, K., A resurgence of beta-lactamase inhibitor combinations effective against multidrug-resistant Gram-negative pathogens. Int. J. Antimicrob. Agents 46 (2015), 483–493.
9. Cherepanov, P.P., Wackernagel, W., Gene disruption in Escherichia coli: TcR and KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance determinant. Gene 158 (1995), 9–14.
10. CLSI, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. M7-A8. 2012, CLSI.
11. Cox, G., Stogios, P.J., Savchenko, A., Wright, G.D., Structural and molecular basis for resistance to aminoglycoside antibiotics by the adenylyltransferase ANT(2')-Ia. mBio, 6, 2015, 10.1128/mBio.02180-14.
12. Datsenko, K.A., Wanner, B.L., One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. USA 97 (2000), 6640–6645.
13. Drawz, S.M., Bonomo, R.A., Three decades of beta-lactamase inhibitors. Clin. Microb. Rev. 23 (2010), 160–201.
14. Drewry, D.H., Willson, T.M., Zuercher, W.J., Seeding collaborations to advance kinase science with the GSK published kinase inhibitor set (PKIS). Curr. Top. Med. Chem. 14 (2014), 340–342.
15. Eisman, P.C., Marsh, W.S., Mayer, R.L., Differentiation of antibiotics by resistant strains. Science, 103, 1946, 673.
16. Elkins, J.M., Fedele, V., Szklarz, M., Abdul Azeez, K.R., Salah, E., Mikolajczyk, J., Romanov, S., Sepetov, N., Huang, X.P., Roth, B.L., et al. Comprehensive characterization of the published kinase inhibitor set. Nat. Biotech. 34 (2016), 95–103.
17. Gaudencio, S.P., Pereira, F., Dereplication: racing to speed up the natural products discovery process. Nat. Prod. Rep. 32 (2015), 779–810.
18. Hirsch, D.R., Cox, G., D'Erasmo, M.P., Shakya, T., Meck, C., Mohd, N., Wright, G.D., Murelli, R.P., Inhibition of the ANT(2”)-Ia resistance enzyme and rescue of aminoglycoside antibiotic activity by synthetic alpha-hydroxytropolones. Bioorg. Med. Chem. Lett. 24 (2014), 4943–4947.
19. Ito, T., Masubuchi, M., Dereplication of microbial extracts and related analytical technologies. J. Antibiot. 67 (2014), 353–360.
20. Jones, K.L., Fresh isolates of actinomycetes in which the presence of sporogenous aerial mycelia is a fluctuating characteristic. J. Bacteriol. 57 (1949), 141–145.
21. King, A.M., Reid-Yu, S.A., Wang, W., King, D.T., De Pascale, G., Strynadka, N.C., Walsh, T.R., Coombes, B.K., Wright, G.D., Aspergillomarasmine A overcomes metallo-beta-lactamase antibiotic resistance. Nature 510 (2014), 503–506.
22. Koster, W., Braun, V., Iron hydroxamate transport of Escherichia coli: nucleotide sequence of the fhuB gene and identification of the protein. Mol. Gen. Genet. 204 (1986), 435–442.
23. Lanoot, B., Vancanneyt, M., Dawyndt, P., Cnockaert, M., Zhang, J., Huang, Y., Liu, Z., Swings, J., BOX-pCR fingerprinting as a powerful tool to reveal synonymous names in the genus Streptomyces. Emended descriptions are proposed for the species Streptomyces cinereorectus, S. fradiae, S. tricolor, S. colombiensis, S. filamentosus, S. vinaceus and S. phaeopurpureus. Syst. App. Microb. 27 (2004), 84–92.
24. Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A.K., Wertheim, H.F., Sumpradit, N., Vlieghe, E., Hara, G.L., Gould, I.M., Goossens, H., et al. Antibiotic resistance-the need for global solutions. Lancet Infect. Dis. 13 (2013), 1057–1098.
25. Ling, L.L., Schneider, T., Peoples, A.J., Spoering, A.L., Engels, I., Conlon, B.P., Mueller, A., Schaberle, T.F., Hughes, D.E., Epstein, S., et al. A new antibiotic kills pathogens without detectable resistance. Nature 517 (2015), 455–459.
26. Mangat, C.S., Bharat, A., Gehrke, S.S., Brown, E.D., Rank ordering plate data facilitates data visualization and normalization in high-throughput screening. J. Biomol. Screen. 19 (2014), 1314–1320.
27. Miller, G.H., Sabatelli, F.J., Hare, R.S., Glupczynski, Y., Mackey, P., Shlaes, D., Shimizu, K., Shaw, K.J., The most frequent aminoglycoside resistance mechanisms – changes with time and geographic area: a reflection of aminoglycoside usage patterns? Aminoglycoside Resistance Study Groups. Clin. Infect. Dis. 24:Suppl 1 (1997), S46–S62.
28. Nielsen, K.F., Mansson, M., Rank, C., Frisvad, J.C., Larsen, T.O., Dereplication of microbial natural products by LC-DAD-TOFMS. J. Nat. Prod. 74 (2011), 2338–2348.
29. Oliynyk, M., Samborskyy, M., Lester, J.B., Mironenko, T., Scott, N., Dickens, S., Haydock, S.F., Leadlay, P.F., Complete genome sequence of the erythromycin-producing bacterium Saccharopolyspora erythraea NRRL23338. Nat. Biotech. 25 (2007), 447–453.
30. Pawlowski, A.C., Johnson, J.W., Wright, G.D., Evolving medicinal chemistry strategies in antibiotic discovery. Curr. Opin. Biotech. 42 (2016), 108–117.
31. Pramanik, A., Braun, V., Albomycin uptake via a ferric hydroxamate transport system of Streptococcus pneumoniae R6. J. Bacteriol. 188 (2006), 3878–3886.
32. Reading, C., Cole, M., Clavulanic acid: a beta-lactamase-inhibiting beta-lactam from Streptomyces clavuligerus. Antimicrob. Agents Chemother. 11 (1977), 852–857.
33. Reynolds, D.M., Waksman, S.A., Grisein, an antibiotic produced by certain strains of Streptomyces griseus. J. Bacteriol. 55 (1948), 739–752.
34. Schneemann, I., Kajahn, I., Ohlendorf, B., Zinecker, H., Erhard, A., Nagel, K., Wiese, J., Imhoff, J.F., Mayamycin, a cytotoxic polyketide from a Streptomyces strain isolated from the marine sponge Halichondria panicea. J. Nat. Prod. 73 (2010), 1309–1312.
35. Schneider, C.A., Rasband, W.S., Eliceiri, K.W., NIH image to ImageJ: 25 years of image analysis. Nat. Methods 9 (2012), 671–675.
36. Shaw, K.J., Rather, P.N., Hare, R.S., Miller, G.H., Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiol. Microb. Rev. 57 (1993), 138–163.
37. Shimizu, K., Kumada, T., Hsieh, W.C., Chung, H.Y., Chong, Y., Hare, R.S., Miller, G.H., Sabatelli, F.J., Howard, J., Comparison of aminoglycoside resistance patterns in Japan, Formosa, and Korea, Chile, and the United States. Antimicrob. Agents Chemother. 28 (1985), 282–288.
38. Socha, A.M., Laplante, K.L., Russell, D.J., Rowley, D.C., Structure-activity studies of echinomycin antibiotics against drug-resistant and biofilm-forming Staphylococcus aureus and Enterococcus faecalis. Bioorg. Med. Chem. Lett. 19 (2009), 1504–1507.
39. Stansly, P.G., The presumptive identification of antibiotics. Science 103 (1946), 402–403.
40. Stapley, E.O., Cross-resistance studies and antibiotic identification. Appl. Microbiol. 6 (1958), 392–398.
41. Stapley, E.O., Ormond, R.E., Similarity of albomycin and grisein. Science 125 (1957), 587–589.
42. Tawfike, A.F., Viegelmann, C., Edrada-Ebel, R., Metabolomics and dereplication strategies in natural products. Methods Mol. Biol. 1055 (2013), 227–244.
43. Thaker, M.N., Wang, W., Spanogiannopoulos, P., Waglechner, N., King, A.M., Medina, R., Wright, G.D., Identifying producers of antibacterial compounds by screening for antibiotic resistance. Nat. Biotech. 31 (2013), 922–927.
44. Verma, M., Kaur, J., Kumar, M., Kumari, K., Saxena, A., Anand, S., Nigam, A., Ravi, V., Raghuvanshi, S., Khurana, P., et al. Whole genome sequence of the rifamycin B-producing strain Amycolatopsis mediterranei S699. J. Bacteriol. 193 (2011), 5562–5563.
45. Watanabe, K., Hotta, K., Praseuth, A.P., Koketsu, K., Migita, A., Boddy, C.N., Wang, C.C., Oguri, H., Oikawa, H., Total biosynthesis of antitumor nonribosomal peptides in Escherichia coli. Nat. Chem. Biol. 2 (2006), 423–428.
46. Wright, G.D., Resisting resistance: new chemical strategies for battling superbugs. Chem. Biol. 7 (2000), R127–R132.
47. Zeng, Y., Roy, H., Patil, P.B., Ibba, M., Chen, S., Characterization of two seryl-tRNA synthetases in albomycin-producing Streptomyces sp. strain ATCC 700974. Antimicrob. Agents Chemother. 53 (2009), 4619–4627.
48. Zeng, Y., Kulkarni, A., Yang, Z., Patil, P.B., Zhou, W., Chi, X., Van Lanen, S., Chen, S., Biosynthesis of albomycin delta(2) provides a template for assembling siderophore and aminoacyl-tRNA synthetase inhibitor conjugates. ACS. Chem. Biol. 7 (2012), 1565–1575.
49. Zhang, J.H., Chung, T.D., Oldenburg, K.R., A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 4 (1999), 67–73.
50. Zhao, W., Zhong, Y., Yuan, H., Wang, J., Zheng, H., Wang, Y., Cen, X., Xu, F., Bai, J., Han, X., et al. Complete genome sequence of the rifamycin SV-producing Amycolatopsis mediterranei U32 revealed its genetic characteristics in phylogeny and metabolism. Cell. Res. 20 (2010), 1096–1108.